Le Lézard
Classified in: Health, Science and technology

Xtalks Announces its Life Science Webinar Calendar for December 2022


Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, commercialization & HEOR, drug discovery & development, healthcare, food, fundamental research, laboratory technology, medical device, pharma manufacturing and supply chain, pharmaceutical, pharmaceutical regulation, pharmacovigilance and preclinical.

TORONTO, Ontario, Dec. 7, 2022 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Visit http://www.xtalks.com to see our upcoming webinars:

CLINICAL TRIALS
December 1- How To Accelerate & Improve the Quality of CDISC SDTM Deliverables: Design with the End in Mind
December 8- Optimizing Patient Care & Clinical Research: How HCPs can Leverage Data Insights & Analytics
December 9- A Tumor Microenvironment-Based Multiomics Analysis for Predictive Modelling
December 12- A Review of Cloud Technology & Solutions that Solve Clinical Trial Challenges
December 12- How to Cut Clinical Study Build Times By 50 percent ? Modern Lessons Learned by Syneos Health
December 13- Getting Neuroimaging Right ? How to Succeed in Neurodegenerative Clinical Trials
December 14- Home Health: Best Practices and Processes to Build Confidence in the Value of In-Home Services
December 15- Bringing the Clinical Trial to the Patient in Preclinical Alzheimer's Disease

COMMERCIALIZATION & HEOR
December 7- The Future of Real-World Evidence: Pharma's Next Moves

DRUG DISCOVERY & DEVELOPMENT
December 1- Utilizing State-of-the-Art DEL Technology to Discover Compounds that Hit Challenging Therapeutic Targets
December 6- Downstream Process Development of a Complicated Fusion Protein
December 7- Nitrosamine Impurities in Rifampin ? What Does it Mean for Your Drug-Drug Interaction (DDI) Study?
December 9- Gene Therapies and Rare Diseases: Advancing Research with Humanized Models and AI
December 14- Building Efficiency into Biologics Formulations Development
December 15- Rational Design of Peptide Nucleic Acid Conjugates for Biomedical Applications
December 15- NGS Solutions for FFPE Materials ? Maximizing Immuno-Oncology Insights with Challenging Clinical Samples

FOOD
December 14- Healthy Aging and Well-Being with Mediterranean Fruit and Vegetable Extracts ? Part 2

FUNDAMENTAL RESEARCH
December 16- Environmental Monitoring: Evaluating Cellular Response Pathways in Complex Mixtures

HEALTHCARE
December 5- Building Next: 3 Ways to Respond to Shifts in Healthcare Realities in 2023 and Beyond
December 12- Leveraging Rapid Multiplex Testing During the Height of Respiratory Season

LABORATORY TECHNOLOGY
December 2- Medical Imaging in R&D ? Streamlining Reader Workflows
December 2- Liquid Biopsy Assays: Beyond Recurrence Detection in Post-Diagnosis Cancer Management
December 5- The Clinical Impact of Early Detection of Extended-Spectrum Beta Lactamase (ESBL) Bacteremia in Hospitalized Patients
December 8- Dive Deep Into AAV Capsid Stability & Genome Ejection With Uncle
December 8- Opportunities and Challenges of Developing and Validating qPCR Assays in Pivotal Vaccine Trials and Beyond

MEDICAL DEVICE
December 2- Medical Device Safety ? How to Improve Histopathological Evaluations

PHARMA MANUFACTURING AND SUPPLY CHAIN
December 6- Choosing the Right eQMS: How one Pharmaceutical Company Gained Incredible Results
December 8- A Stagewise Approach to High Potency Drug Product Clinical Development & Commercialization
December 13- The Pivotal Role of the System Owner ? From Project to Operations
December 13- A Strain Development Strategy to Enhance Screening, Process Development and Scale-Up

PHARMACEUTICAL
December 16- T3P ? A Versatile Peptide Coupling and Water Removal Reagent, Offering Several Process Advantages

PHARMACEUTICAL REGULATION
December 5- An Accelerated Approach to Strategic Regulatory Compliance

PHARMACOVIGILANCE
December 7- Effective Pharmacovigilance Content Collaboration with Cloud Technologies

PRECLINICAL
December 14- Translational Research in Oncology ? Innovations in Model Development

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com.

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x 272, [email protected]

 

SOURCE Xtalks


These press releases may also interest you

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...

at 17:00
L.A. Care Health Plan and Blue Shield of California Promise Health Plan today held a grand opening ceremony for their Community Resource Center (CRC) in West Los Angeles (West L.A.) at 11173 W. Pico Blvd in Los Angeles....

at 16:55
Veterinary Management Groups (VMG) is proud to...

at 16:45
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20, 2024, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered...



News published on and distributed by: